0

Journal Articles

in Oncology
 61-80 of 1041 Articles
Lab Reports |  July 04, 2012
Cancer Cells’ Reliance on Glycine
Tracy Hampton, PhD
JAMA. 2012;308(1):21. doi:10.1001/jama.2012.7375.
Health Agencies Update |  June 27, 2012
Mining Cast-off Drugs
Bridget M. Kuehn
JAMA. 2012;307(24):2578. doi:10.1001/jama.2012.7066.
Medical News and Perspectives |  June 20, 2012
Screening Women for Ovarian Cancer Still Does More Harm Than Good
Anita Slomski
JAMA. 2012;307(23):2474-2475. doi:10.1001/jama.2012.5646.
Review |  June 13, 2012 FREE
Benefits and Harms of CT Screening for Lung Cancer:  A Systematic Review
Peter B. Bach, MD, MAPP; Joshua N. Mirkin, BA; Thomas K. Oliver, BA; et al.
JAMA. 2012;307(22):2418-2429. doi:10.1001/jama.2012.5521.
INCLUDES: CME
Editorial |  June 13, 2012 FREE
Lung Cancer Screening, Radiation, Risks, Benefits, and Uncertainty
George T. O’Connor, MD, MS; Hiroto Hatabu, MD, PhD
JAMA. 2012;307(22):2434-2435. doi:10.1001/jama.2012.6096.
Medical News and Perspectives |  May 23, 2012
Rigorous Evidence Slim for Determining Health Risks From Natural Gas Fracking
Mike Mitka
JAMA. 2012;307(20):2135-2136. doi:10.1001/jama.2012.3726.
Viewpoint |  May 02, 2012
Choosing Wisely:  Helping Physicians and Patients Make Smart Decisions About Their Care
Christine K. Cassel, MD; James A. Guest, JD
JAMA. 2012;307(17):1801-1802. doi:10.1001/jama.2012.476.
Research Letters |  April 25, 2012 FREE
2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates
Sandip M. Prasad, MD, MPhil; Michael W. Drazer, BA; Dezheng Huo, MD, PhD; et al.
JAMA. 2012;307(16):1692-1694. doi:10.1001/jama.2012.534.
Medical News & Perspectives |  April 25, 2012
Media Lab Uses Videos, Comics, and More to Help People Understand Health Issues
Tracy Hampton, PhD
JAMA. 2012;307(16):1679-1680. doi:10.1001/jama.2012.507.
Original Contribution |  April 18, 2012 FREE
Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer
Nathan C. Sheets, MD; Gregg H. Goldin, MD; Anne-Marie Meyer, PhD; et al.
JAMA. 2012;307(15):1611-1620. doi:10.1001/jama.2012.460.
INCLUDES: , Supplemental Content
Original Contribution |  April 18, 2012 FREE
Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non–Small Cell Lung Cancer
Junya Zhu, MS, MA; Dhruv B. Sharma, PhD; Stacy W. Gray, MD, AM; et al.
JAMA. 2012;307(15):1593-1601. doi:10.1001/jama.2012.454.
INCLUDES: , Supplemental Content
Editorial |  April 04, 2012
Antitumor Activity in Metastatic Disease Does Not Predict Efficacy in the Adjuvant Setting
Neil H. Segal, MD, PhD; Leonard B. Saltz, MD
JAMA. 2012;307(13):1431-1432. doi:10.1001/jama.2012.410.
Lab Reports |  April 04, 2012
NSAIDs and Cancer Spread
Tracy Hampton, PhD
JAMA. 2012;307(13):1357. doi:10.1001/jama.2012.373.
Original Contribution |  April 04, 2012 FREE
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer:  A Randomized Trial
Steven R. Alberts, MD; Daniel J. Sargent, PhD; Suresh Nair, MD; et al.
JAMA. 2012;307(13):1383-1393. doi:10.1001/jama.2012.385.
INCLUDES: , Supplemental Content
Original Contribution |  April 04, 2012 FREE
Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk
Wendie A. Berg, MD, PhD; Zheng Zhang, PhD; Daniel Lehrer, MD; et al.
JAMA. 2012;307(13):1394-1404. doi:10.1001/jama.2012.388.
INCLUDES: , Supplemental Content
Viewpoint |  April 04, 2012
The Challenge of Individualizing Treatments for Patients With Breast Cancer
Steven J. Katz, MD, MPH; Monica Morrow, MD
JAMA. 2012;307(13):1379-1380. doi:10.1001/jama.2012.409.
Clinical Crossroads |  April 04, 2012
Management of Ovarian Cancer:  A 75-Year-Old Woman Who Has Completed Treatment
Panagiotis A. Konstantinopoulos, MD, PhD; Christopher S. Awtrey, MD
JAMA. 2012;307(13):1420-1429. doi:10.1001/jama.2012.269.
INCLUDES: CME , Supplemental Content
Editorial |  March 28, 2012
Optimal Duration of Adjuvant Therapy for Patients With Resected Gastrointestinal Stromal Tumors
Charles D. Blanke, MD, FRCPC
JAMA. 2012;307(12):1312-1314. doi:10.1001/jama.2012.368.
Original Contribution |  March 28, 2012 FREE
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor:  A Randomized Trial
Heikki Joensuu, MD; Mikael Eriksson, MD; Kirsten Sundby Hall, MD; et al.
JAMA. 2012;307(12):1265-1272. doi:10.1001/jama.2012.347.
Capitol Health Call |  March 14, 2012
Whistle-blower Treatment
Mike Mitka
JAMA. 2012;307(10):1015. doi:10.1001/jama.2012.257.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis:  Analysis of 7872 Consecutive Eyes
Carol L. Shields, MD; Swathi Kaliki, MD; Michael Livesey, BS; et al.
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  May 16, 2013
An Oral Cavity Carcinoma Nomogram to Predict Benefit of Adjuvant Radiotherapy
Samuel J. Wang, MD, PhD; Snehal G. Patel, MD; Jatin P. Shah, MD; et al.
JAMA Internal Medicine
Original Investigation  |  March 18, 2013
Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy
Karla Kerlikowske, MD; Weiwei Zhu, MS; Rebecca A. Hubbard, PhD; et al.
JAMA Internal Medicine
Viewpoint  |  April 1, 2013
Not Just Words:  Caring for the Patient by Caring About Language
Andrew S. Epstein, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems